Periodic density functional study of Rh and Pd interaction with the (100)MgO surface

The adsorption geometry and electronic properties of palladium and rhodium atoms deposited on the regular (100)MgO surface were analyzed by means of periodic DFT calculations using local, gradient-corrected and hybrid (B3LYP) functionals. Spin-polarized computations revealed doublet spin state of Rh atom to be the most stable electronic state for the adsorbed rhodium atom on (100)MgO. The preferred adsorption site of the metal (Pd and Rh) atoms was found to be the site on top of the surface oxygen atoms. A relatively stable geometry for the adsorption of the Pd and Rh in a bridge position above the two surface oxygens was found as well. The electronic structures suggested partly covalent bonding with contribution from electrostatic attraction between the metal and the oxygen atoms for both optimized structures. Small charge transfer was obtained from the support to the Pd and Rh metal atoms. The calculations showed that rhodium was bound stronger to the substrate probably due to stronger polarization effects

A DFT study of the NO adsorption on Pdn (n = 1–4) clusters

We report a density-functional study of some properties of the adsorption process of the NO molecule on small palladium clusters (n = 1–4). The interaction between NO and the Pdn clusters is studied on various adsorption sites. Both, NO and Pdn geometrical relaxations are taken into account. The significant conformational reconstruction of the metallic cluster upon NO adsorption induces a large decrease of the NO adsorption energy. Nevertheless, the N–O binding energy is strongly weakened when the molecule is adsorbed on the small Pdn clusters due essentially to an electrostatic repulsion between both N and O atoms. The possible dissociation process of NO on Pd4 cluster is then investigated within two processes: the NO molecule does not dissociate on Pd4 with process (i) (dissociation of the isolated gas phase NO molecule followed by the adsorption of both nitrogen and oxygen atoms on the cluster). Process (ii)which presents three successive steps (adsorption of the NO molecule, dissociation of the NO molecule adsorbed on Pd4, adsorption of the O atom on the cluster) is studied in details and we propose a reaction pathway locating transition states and intermediate species. The activation energy for process (ii) is high and the dissociation of the NO molecule on the Pd4 cluster is thus highly improbable

Anticancer Activity, Reduction Mechanism and G-Quadruplex DNA Binding of a Redox-Activated Platinum(IV)–Salphen Complex

Aiming at reducing the unselective cytotoxicity of Pt(II) chemotherapeutics, a great deal of effort has been concentrated into the design of metal‐containing drugs with different anticancer mechanisms of action. Inert Pt(IV) prodrugs have been proposed to be a valid alternative as they are activated by reduction directly into the cell releasing active Pt(II) species. On the other hand, a promising strategy for designing metallodrugs is to explore new potential biological targets rather than canonical B‐DNA. G‐quadruplex nucleic acid, obtained by self‐assembly of guanine‐rich nucleic acid sequences, has recently been considered an attractive target for anticancer drug design. Therefore, compounds capable of binding and stabilizing this type of DNA structure would be greatly beneficial in anticancer therapy. Here, computational analysis reports the mechanism of action of a recently synthesized Pt(IV)–salphen complex conjugating the inertness of Pt(IV) prodrugs with the ability to bind G‐quadruplexes of the corresponding Pt(II) complex. The reduction mechanism of the Pt(IV) complex with a biological reducing agent was investigated in depth by means of DFT, whereas classical MD simulations were carried out to shed light into the binding mechanism of the released Pt(II) complex. The results show that the Pt(IV) prodrug may be reduced by both inner‐ and outer‐sphere mechanisms, and the active Pt(II) complex, as a function of its protonation state, stabilizes the G‐quadruplex DNA prevalently, either establishing π‐stacking nteractions with the terminal G‐tetrad or through electrostatic interactions along with H‐bonds formation

Glutathione activation of an organometallic half-sandwich anticancer drug candidate by ligand attack

Density functional theory calculations and X-ray absorption spectroscopic data suggest an unusual activation mechanism for this potent Os anticancer complex: catalytic attack by intracellular thiol glutathione on the azo bond of the chelated ligand

Can BODIPY Dimers Act as Photosensitizers in Photodynamic Therapy? A Theoretical Prediction

The photophysical properties of some monomeric and dimeric BODIPY systems were investigated at the density functional theory level and herein reported. In particular, the absorption spectra were fully characterized, low energy singlet and triplet excited states were discussed also focusing on the energy difference gaps between them and computing the spin-orbit couplings values for the possible intersystem crossing channels. The heavy atom effect of iodine substituents on the photophysical properties of a monomer and on a dimer under investigation was also estimated. Results obtained on the considered compounds allow us to predict which is the most promising candidate to be suggested as a photosensitizer in photodynamic therapy

Tuning the photoactivated anticancer activity of Pt( iv ) compounds via distant ferrocene conjugation

Photoactive prodrugs offer potential for spatially-selective antitumour activity with minimal effects on normal tissues. Excited-state chemistry can induce novel effects on biochemical pathways and combat resistance to conventional drugs. Photoactive metal complexes in particular, have a rich and relatively unexplored photochemistry, especially an ability to undergo facile intersystem crossing and populate triplet states. We have conjugated the photoactive octahedral Pt(iv) complex trans, trans, trans-[Pt(N3)2(OH)2(py)2] to ferrocene to introduce novel features into a candidate photochemotherapeutic drug. The X-ray crystal structure of the conjugate Pt-Fe confirmed the axial coordination of a ferrocene carboxylate, with Pt(iv) and Fe(ii) 6.07 Å apart. The conjugation of ferrocene red-shifted the absorption spectrum and ferrocene behaves as a light antenna allowing charge transfer from iron to platinum, promoting the photoactivation of Pt-Fe with light of longer wavelength. Cancer cellular accumulation is enhanced, and generation of reactive species is catalysed after photoirradiation, introducing ferroptosis as a contribution towards the cell-death mechanism. TDDFT calculations were performed to shed light on the behaviour of Pt-Fe when it is irradiated. Intersystem spin-crossing allows the formation of triplet states centred on both metal atoms. The dissociative nature of triplet states confirms that they can be involved in ligand detachment due to irradiation. The Pt(ii) photoproducts mainly retain the trans-{Pt(py)2}2+fragment. Visible light irradiation gives rise to micromolar activity for Pt-Fe towards ovarian, lung, prostate and bladder cancer cells under both normoxia and hypoxia, and some photoproducts appear to retain Pt(iv)–Fe(ii) conjugation